MUSLIMA BILLAH: Open Payments
NPI 1124596192 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$896 in 45 payments from 14 companies in 2025. Trend: 2023 $735 · 2024 $1,097 · 2025 $896
Food & beverage: $735Education: $161
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $309 |
| Exact Sciences Corporation | 4 | $88 |
| Lilly USA, LLC | 4 | $77 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| Corcept Therapeutics | 2 | $59 |
| ALK-Abello, Inc | 2 | $47 |
| PFIZER INC. | 2 | $44 |
| ABBVIE INC. | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Phathom Pharmaceuticals, Inc. | 4 | $33 |
Products named: Wegovy, Ozempic, FARXIGA, The Cologuard Plus Collection Kit, Korlym, Rybelsus, MOUNJARO, XIFAXAN.
Industry payments across UT — which companies pay providers there.
